Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children (Q34157657)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children (English)

1 reference

Europe PubMed Central

31 July 2017

methicillin-resistant Staphylococcus aureus

0 references

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

Infectious Diseases Society of America

14

object named as

Infectious Diseases Society of America

1 reference

Europe PubMed Central

31 July 2017

4

object named as

Robert S Daum

1 reference

Europe PubMed Central

31 July 2017

Michael J Rybak

11

object named as

Michael J Rybak

1 reference

Europe PubMed Central

31 July 2017

2

object named as

Arnold Bayer

1 reference

Europe PubMed Central

31 July 2017

Henry F Chambers

13

object named as

Henry F Chambers

1 reference

Europe PubMed Central

31 July 2017

Scott K Fridkin

5

object named as

Scott K Fridkin

1 reference

Europe PubMed Central

31 July 2017

6

object named as

Rachel J Gorwitz

1 reference

Europe PubMed Central

31 July 2017

Sara E Cosgrove

3

object named as

Sara E Cosgrove

1 reference

Europe PubMed Central

31 July 2017

author name string

Catherine Liu

1

1 reference

Europe PubMed Central

31 July 2017

Sheldon L Kaplan

7

1 reference

Europe PubMed Central

31 July 2017

Adolf W Karchmer

8

1 reference

Europe PubMed Central

31 July 2017

Donald P Levine

9

1 reference

Europe PubMed Central

31 July 2017

Barbara E Murray

10

1 reference

Europe PubMed Central

31 July 2017

David A Talan

12

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

4 January 2011

1 reference

Europe PubMed Central

31 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

31 July 2017

52

1 reference

Europe PubMed Central

31 July 2017

e18-55

1 reference

Europe PubMed Central

31 July 2017

3

1 reference

Europe PubMed Central

31 July 2017

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children's Health Plan.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pediatric mediastinitis as a complication of methicillin-resistant Staphylococcus aureus retropharyngeal abscess

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Venous thrombosis and thromboembolism in children with osteomyelitis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Purpura fulminans due to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Concentration of clindamycin in human bone

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA).

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Peripheral neuropathy associated with prolonged use of linezolid

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Serotonin syndrome and linezolid

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Hematologic effects of linezolid in young children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Safety and tolerability of linezolid in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

In vivo verification of in vitro model of antibiotic treatment of device-related infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Telavancin: a novel lipoglycopeptide

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Gene heterogeneity for tetracycline resistance in Staphylococcus spp.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Methicillin-resistant Staphylococcus aureus disease in three communities

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Limitations of vancomycin in the management of resistant staphylococcal infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin concentrations in infected and noninfected human bone

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Trends in US hospital admissions for skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Videos in clinical medicine. Abscess incision and drainage.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Community-associated meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid: the first oxazolidinone antimicrobial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Antimicrobial Susceptibility and Survey of Macrolide Resistance Mechanisms amongStreptococcus pyogenesIsolated in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Three-year surveillance of community-acquired Staphylococcus aureus infections in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Cellulitis: a prospective study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid for the treatment of complicated skin and skin structure infections in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Preventing surgical-site infections in nasal carriers of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Mupirocin resistance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

A clone of methicillin-resistant Staphylococcus aureus among professional football players.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Panton-valentine leukocidin and staphyloccoccal skin infections in schoolchildren

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus endocarditis: a consequence of medical progress

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin therapy for invasive Gram-positive bacterial infections in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Management of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Valve replacement in patients with native valve endocarditis: what really determines operative outcome?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Long-term outcome of infective endocarditis: the impact of early surgical intervention.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Penetration of vancomycin into human lung tissue

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Intrapulmonary pharmacokinetics of linezolid

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Septic arthritis: current diagnostic and therapeutic algorithm

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Infection and musculoskeletal conditions: Osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Antibiotic treatment of gram-positive bone and joint infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Systematic review and meta-analysis of antibiotic therapy for bone and joint infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE Registry

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical experience with daptomycin for the treatment of patients with osteomyelitis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Experience with linezolid therapy in children with osteoarticular infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid in the treatment of osteomyelitis: results of compassionate use experience

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Prosthetic-joint infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The management and outcome of spinal implant infections: contemporary retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Infection following operative treatment of ankle fractures

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

A comparison of early versus late conversion from intravenous to oral therapy in the treatment of septic arthritis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Effect of linezolid against postneurosurgical meningitis caused by methicillin-resistant Staphylococcus epidermidis: case report

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Trimethoprim-Sulfamethoxazole for Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid for the treatment of patients with central nervous system infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Treatment of cerebrospinal fluid shunt infections: a decision analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Nosocomial bacterial meningitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Conservative management of patients with cerebrospinal fluid shunt infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Septic thrombosis of the dural venous sinuses

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Necessity of a loading dose when using vancomycin in critically ill patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin ototoxicity: a reevaluation in an era of increasing doses

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid and rifampin: Drug interaction contrary to expectations?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Linezolid therapy for infective endocarditis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIQ146

21 January 2018

Identifiers

10.1093/CID/CIQ146

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34157657&oldid=1796114124"